21 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents ... (DOACS + Warfarin ... #DOAC #Dosing #Oral ... #Table #Pharmacology
Warfarin and DOAC Pharmacology
Warfarin - Dabigatran - Rivaroxaban - Apixaban - Edoxaban
Target - Prodrug - Bioavailability
Warfarin and DOAC ... Plasma Protein Binding ... Elimination - Peak ... h) #Warfarin #DOAC ... #comparison #table
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
& Vasopressor Dosing ... Paralytic Agents ... resuscitation #table ... #pharmacology #dosing ... #medications #Comparison
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
New Potassium-Binding ... Agents - Dr. ... #Potassium #Binding ... KBinders #Kayexelate #Comparison ... #Table #Pharmacology
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... Cessation #Therapy #Comparison ... #Table #Agents ... #Dosing
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... anticoagulants (DOACs ... for appropriate dosing ... vein thrombosis; PE ... #Cancer #Algorithm
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
onset of action, peak ... #pharmacology #table ... #comparison #dosing
Review of Intranasally Administered Medications for Use in the Emergency Department
Table of agents, uses, dosing, onset
of agents, uses ... , dosing, onset ... #Medications #Comparison ... #Table #Dosing ... #Pharmacology #PSA
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... aspiration #Potassium #Binding ... #pharmacology #table ... #comparison #binders
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
incidental DVT or PE ... single subsegmental PE ... bleeding risk during ... DOAC, direct oral ... #DOAC #VTE #Malignancy